Payouts to shareholders of large publicly traded health companies more than tripled over the past two decades, new research shows ...
Sitting at a market capitalization of $159 billion, Amgen (AMGN) is a biotech powerhouse. Founded in 1980, it is one of the biggest names in the healthcare and biotech industry, with a strong history ...
Dallas Goedert details how the team's victory in Super Bowl LIX is even "more sweet" considering what the Eagles went through ...
Amgen (NASDAQ:AMGN – Get Free Report) had its target price increased by Piper Sandler from $310.00 to $329.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results